Literature DB >> 35383049

Retinal nerve fibre layer thickness measured with SD-OCT in a population-based study: the Handan Eye Study.

Jian Wu1,2, Yifan Du1, Caixia Lin1, Yingting Zhu3, Wei Chen2, Qing Pan4, Yehong Zhuo3, Ningli Wang5.   

Abstract

PURPOSE: To examine the normative profile of retinal nerve fibre layer (RNFL) thickness and ocular parameters based on spectral-domain optical coherence tomography (SD-OCT) and its associations with related parameters among the Chinese population.
METHODS: This population-based cohort Handan Eye Study (HES) recruited participants aged≥30 years. All subjects underwent a standardised ophthalmic examination. Peripapillary RNFL thickness was obtained using SD-OCT. Mixed linear models were adopted to evaluate the correlation of RNFL thickness with ocular parameters as well as systemic factors. R V.3.6.1 software was used for statistical analysis.
RESULTS: 3509 subjects (7024 eyes) with the average age of 55.54±10.37 were collected in this analysis. Overall mean RNFL thickness measured was 113.46±10.90 µm, and the thickest quadrant of parapapillary RNFL was the inferior quadrant, followed by the superior quadrant, the nasal quadrant and the temporal quadrant. In the multivariate linear regression model, thinner RNFL thickness was remarkable association with male (p<0.001), older age (p<0.001), increased body mass index (>30, p=0.018), absence of diabetes (p=0.009), history of cataract surgery (p=0.001), higher intraocular pressure (p=0.007), lower spherical equivalent (p<0.001) and increased axial length (p=0.048).
CONCLUSIONS: In non-glaucoma individuals, this difference of RNFL thickness in Chinese population should be noted in making disease diagnoses. Meanwhile, multiple ocular and systemic factors are closely related to the thickness of RNFL. Our findings further emphasise the need to demonstrate ethnic differences in RNFL thickness and the specificity of associated ocular and systemic factors, as well as to develop better normative databases worldwide. TRIAL REGISTRATION NUMBER: HES was registered in Chinese Clinical Trial Registry website, and the registry number was ChiCTR-EOC-17013214. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  epidemiology; optic nerve; retina

Year:  2022        PMID: 35383049     DOI: 10.1136/bjophthalmol-2021-320618

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  2 in total

1.  Deep learning: Opening a third eye to myocardial perfusion imaging.

Authors:  Tomoe Hagio; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2022-05-12       Impact factor: 5.952

2.  Quantitative evaluation of intraorbital optic nerve in optic atrophy using diffusion tensor imaging.

Authors:  Eun Hee Hong; Jin-Ju Yang; Yeji Yeon; Hyun Soo Cho; Ji Young Lee; Won June Lee; Yu Jeong Kim; Yeji Moon; Han Woong Lim
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.